The Last Disease Z

Bublig · 2026 · $8.99 · Action · deal grade C

Measured on 2026-09-23 20:25 UTC, 21 days ago. The whole catalog is re-measured daily; a game that just launched can move fast between passes.

• Estimated net residual revenue: $4.8k to $7.2k per month
• Opportunity: $6.0k per month at x1.00 dormancy
• Estimated lifetime owners: 3.3k
• 55% positive across 83 reviews · 79.0 reviews/month

Why it's flagged

• Developer active, last post 0 months ago
• Last discounted 1 months ago, 1 sales in the last 12 months

Analyst notes (AI-assisted)

Note written 2026-08-28; the live figures above take precedence over any numbers in it.

The Last Disease Z is an early-access survival-crafting game with zombies, base building, and cooperative multiplayer set in a low-poly open world.

This title sits in a crowded survival-crafting niche dominated by established franchises (DayZ, Rust), yet maintains modest residual revenue with a small but engaged core audience. The polarized review sentiment reflects typical EA growing pains: core systems work, but content density, balance, and UX need substantial iteration before it can compete for mainstream attention. Most relevant for publishers seeking a dormant catalog title with low upside but stable margins, or for a developer evaluating technical debt and player feedback loops on a shoestring budget. Most realistic play: watch.

• Risk: Survival-crafting genre is saturated; differentiation versus DayZ, Rust, and Valheim is minimal and not yet evident to players.
• Risk: Persistent reports of UI clutter, audio imbalance, balance tuning (9000 HP boss vs 12 damage axe), and save-file corruption suggest architectural debt.
• Risk: Heavy reliance on community guidance (hidden crafting recipes, remote map resources) indicates poor onboarding and world design communication.

This case as Markdown · Estimates carry ±30-50% error per title.